<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03730753</url>
  </required_header>
  <id_info>
    <org_study_id>2018 - 2686</org_study_id>
    <nct_id>NCT03730753</nct_id>
  </id_info>
  <brief_title>Programmed Intermittent Epidural Bolus Versus Continuous Infusion in Labour Analgesia</brief_title>
  <official_title>Programmed Intermittent Epidural Bolus Versus Continuous Infusion When Added to Patient-controlled Epidural Analgesia on Bupivacaine Consumption in Labour Analgesia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to establish if programmed intermittent epidural bolus combined to patient
      controlled analgesia in labour analgesia will lower the hourly bupivacaine consumption when
      compared to continuous infusion combined with patient controlled analgesia. The
      investigators' hypothesis is that the use of programmed intermittent epidural bolus will
      lower the hourly bupivacaine consumption.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose of bupivacaine in milligrams per hour</measure>
    <time_frame>1 day</time_frame>
    <description>Total dose of bupivacaine in milligrams divided by the total duration of the epidural in hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of pain</measure>
    <time_frame>1 day</time_frame>
    <description>Hourly pain measurement by visual analog scale, 0/10 being no pain and 10/10 being the worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesiologist manual bolus</measure>
    <time_frame>1 day</time_frame>
    <description>Total boluses by the anesthesiologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCEA boluses received</measure>
    <time_frame>1 day</time_frame>
    <description>PCEA boluses received</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCEA boluses requested</measure>
    <time_frame>1 day</time_frame>
    <description>PCEA boluses requested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time lapse before the first PCEA request after the epidural connection</measure>
    <time_frame>1 day</time_frame>
    <description>Time lapse before the first PCEA request after the epidural connection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First stage</measure>
    <time_frame>1 day</time_frame>
    <description>Duration of the first stage of labour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second stage</measure>
    <time_frame>1 day</time_frame>
    <description>Duration of the second stage of labour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assisted vaginal delivery</measure>
    <time_frame>1 day</time_frame>
    <description>Number of assisted vaginal delivery (vacuum, forceps)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean section</measure>
    <time_frame>1 day</time_frame>
    <description>Number of unplanned cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor blockade</measure>
    <time_frame>1 day</time_frame>
    <description>Number of patients with a Bromage score ≥1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 day</time_frame>
    <description>Satisfaction of the analgesia provided by the epidural on a visual analog scale of 0-100, 0/100 being no satisfaction at all and 100/100 being entirely satisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous infusion + patient controlled epidural analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Programmed intermittent epidural bolus + patient controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Programmed intermittent epidural bolus</intervention_name>
    <description>Programmed intermittent epidural bolus added to patient controlled epidural analgesia</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous infusion</intervention_name>
    <description>Continuous infusion added to patient controlled epidural analgesia</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant nulliparous or multiparous woman in labour

          -  Age ≥18 years

          -  Obtained consent for epidural analgesia

          -  ASA classification I-II-III

          -  Early labour (cervical dilation ≤6cm)

        Exclusion Criteria:

          -  Pregnancy-related comorbidities (preeclampsia, eclampsia, gestational diabetes, large
             for gestational age fetus)

          -  Prematurity (&lt;36 weeks of gestation)

          -  Multiple gestation

          -  Fentanyl allergy or hypersensitivity

          -  Patient unable to understand the PCEA

          -  Fetal breech position

          -  Maternal cardiac pathology and contraindication to Valsalva manoeuvre

          -  Patient with a pain visual analog scale (VAS) not ≤1/10 20 minutes after the
             anesthesiologist's initial bolus

          -  Intrathecal catheter or intravascular catheter

          -  Accidental dural puncture

          -  Patient refusal

          -  Patient with a history of chronic pain (pain lasting more than 3 months) or
             fibromyalgia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geneviève Rivard, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle Caron, Dr.</last_name>
    <phone>+1 819 346-1110</phone>
    <phone_ext>5593</phone_ext>
    <email>isabelle.caron4@usherbrooke.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Geneviève Rivard, Dr.</last_name>
    <phone>+1 819 346-1110</phone>
    <phone_ext>0253</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHUS</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genevieve Rivard, FRCPC</last_name>
      <phone>8195651502</phone>
      <email>genevieve.rivard2@usherbrooke.ca</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Caron</last_name>
      <email>isabelle.caron4@usherbrooke.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Liu EH, Sia AT. Rates of caesarean section and instrumental vaginal delivery in nulliparous women after low concentration epidural infusions or opioid analgesia: systematic review. BMJ. 2004 Jun 12;328(7453):1410. Epub 2004 May 28. Review.</citation>
    <PMID>15169744</PMID>
  </reference>
  <reference>
    <citation>Nunes J, Nunes S, Veiga M, Cortez M, Seifert I. A prospective, randomized, blinded-endpoint, controlled study - continuous epidural infusion versus programmed intermittent epidural bolus in labor analgesia. Braz J Anesthesiol. 2016 Sep-Oct;66(5):439-44. doi: 10.1016/j.bjane.2014.12.006. Epub 2015 Nov 19.</citation>
    <PMID>27591455</PMID>
  </reference>
  <reference>
    <citation>Salim R, Nachum Z, Moscovici R, Lavee M, Shalev E. Continuous compared with intermittent epidural infusion on progress of labor and patient satisfaction. Obstet Gynecol. 2005 Aug;106(2):301-6.</citation>
    <PMID>16055579</PMID>
  </reference>
  <reference>
    <citation>Chua SM, Sia AT. Automated intermittent epidural boluses improve analgesia induced by intrathecal fentanyl during labour. Can J Anaesth. 2004 Jun-Jul;51(6):581-5.</citation>
    <PMID>15197122</PMID>
  </reference>
  <reference>
    <citation>Lim Y, Sia AT, Ocampo C. Automated regular boluses for epidural analgesia: a comparison with continuous infusion. Int J Obstet Anesth. 2005 Oct;14(4):305-9.</citation>
    <PMID>16154735</PMID>
  </reference>
  <reference>
    <citation>Lim Y, Chakravarty S, Ocampo CE, Sia AT. Comparison of automated intermittent low volume bolus with continuous infusion for labour epidural analgesia. Anaesth Intensive Care. 2010 Sep;38(5):894-9.</citation>
    <PMID>20865875</PMID>
  </reference>
  <reference>
    <citation>Fettes PD, Moore CS, Whiteside JB, McLeod GA, Wildsmith JA. Intermittent vs continuous administration of epidural ropivacaine with fentanyl for analgesia during labour. Br J Anaesth. 2006 Sep;97(3):359-64. Epub 2006 Jul 18.</citation>
    <PMID>16849382</PMID>
  </reference>
  <reference>
    <citation>Wong CA, Ratliff JT, Sullivan JT, Scavone BM, Toledo P, McCarthy RJ. A randomized comparison of programmed intermittent epidural bolus with continuous epidural infusion for labor analgesia. Anesth Analg. 2006 Mar;102(3):904-9.</citation>
    <PMID>16492849</PMID>
  </reference>
  <reference>
    <citation>Leo S, Ocampo CE, Lim Y, Sia AT. A randomized comparison of automated intermittent mandatory boluses with a basal infusion in combination with patient-controlled epidural analgesia for labor and delivery. Int J Obstet Anesth. 2010 Oct;19(4):357-64. doi: 10.1016/j.ijoa.2010.07.006. Epub 2010 Sep 15.</citation>
    <PMID>20832282</PMID>
  </reference>
  <reference>
    <citation>Tien M, Allen TK, Mauritz A, Habib AS. A retrospective comparison of programmed intermittent epidural bolus with continuous epidural infusion for maintenance of labor analgesia. Curr Med Res Opin. 2016 Aug;32(8):1435-40. doi: 10.1080/03007995.2016.1181619. Epub 2016 May 20.</citation>
    <PMID>27100210</PMID>
  </reference>
  <reference>
    <citation>Sia AT, Lim Y, Ocampo C. A comparison of a basal infusion with automated mandatory boluses in parturient-controlled epidural analgesia during labor. Anesth Analg. 2007 Mar;104(3):673-8.</citation>
    <PMID>17312228</PMID>
  </reference>
  <reference>
    <citation>Capogna G, Camorcia M, Stirparo S, Farcomeni A. Programmed intermittent epidural bolus versus continuous epidural infusion for labor analgesia: the effects on maternal motor function and labor outcome. A randomized double-blind study in nulliparous women. Anesth Analg. 2011 Oct;113(4):826-31. doi: 10.1213/ANE.0b013e31822827b8. Epub 2011 Jul 25.</citation>
    <PMID>21788309</PMID>
  </reference>
  <reference>
    <citation>McKenzie CP, Cobb B, Riley ET, Carvalho B. Programmed intermittent epidural boluses for maintenance of labor analgesia: an impact study. Int J Obstet Anesth. 2016 May;26:32-8. doi: 10.1016/j.ijoa.2015.11.005. Epub 2015 Nov 27.</citation>
    <PMID>26775896</PMID>
  </reference>
  <reference>
    <citation>Epsztein Kanczuk M, Barrett NM, Arzola C, Downey K, Ye XY, Carvalho JC. Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Biased-Coin Up-and-Down Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 10 mL of Bupivacaine 0.0625% With Fentanyl 2 μg/mL. Anesth Analg. 2017 Feb;124(2):537-541. doi: 10.1213/ANE.0000000000001655.</citation>
    <PMID>27755057</PMID>
  </reference>
  <reference>
    <citation>Wong CA, McCarthy RJ, Hewlett B. The effect of manipulation of the programmed intermittent bolus time interval and injection volume on total drug use for labor epidural analgesia: a randomized controlled trial. Anesth Analg. 2011 Apr;112(4):904-11. doi: 10.1213/ANE.0b013e31820e7c2f.</citation>
    <PMID>21430035</PMID>
  </reference>
  <reference>
    <citation>George RB, Allen TK, Habib AS. Intermittent epidural bolus compared with continuous epidural infusions for labor analgesia: a systematic review and meta-analysis. Anesth Analg. 2013 Jan;116(1):133-44. doi: 10.1213/ANE.0b013e3182713b26. Epub 2012 Dec 7. Review. Erratum in: Anesth Analg. 2013 Jun;116(6):1385.</citation>
    <PMID>23223119</PMID>
  </reference>
  <reference>
    <citation>Lee L, Dy J, Azzam H. Management of Spontaneous Labour at Term in Healthy Women. J Obstet Gynaecol Can. 2016 Sep;38(9):843-865. doi: 10.1016/j.jogc.2016.04.093. Epub 2016 Jun 25.</citation>
    <PMID>27670710</PMID>
  </reference>
  <reference>
    <citation>Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med. 1996 Feb;3(2):142-6.</citation>
    <PMID>8808375</PMID>
  </reference>
  <reference>
    <citation>Singer AJ, Thode HC Jr. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med. 1998 Oct;5(10):1007-11.</citation>
    <PMID>9862594</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 27, 2018</study_first_submitted>
  <study_first_submitted_qc>November 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Geneviève Rivard</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Starting 6 months after publication for 5 years</ipd_time_frame>
    <ipd_access_criteria>All access requests and criteria will be reviewed by the investigators of this study.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

